| __timestamp | TG Therapeutics, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31354781 | 18516000 |
| Thursday, January 1, 2015 | 43445817 | 34140000 |
| Friday, January 1, 2016 | 66489820 | 51872000 |
| Sunday, January 1, 2017 | 96886134 | 71772000 |
| Monday, January 1, 2018 | 153793000 | 97501000 |
| Tuesday, January 1, 2019 | 148369000 | 118590000 |
| Wednesday, January 1, 2020 | 151934000 | 169802000 |
| Friday, January 1, 2021 | 198532000 | 192507000 |
| Saturday, January 1, 2022 | 112128000 | 199563000 |
| Sunday, January 1, 2023 | 76192000 | 253598000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Xencor, Inc. have been at the forefront of this race. From 2014 to 2023, Xencor's R&D expenses surged by over 1,270%, peaking in 2023 with a 37% increase from the previous year. Meanwhile, TG Therapeutics saw a more modest growth of approximately 143% over the same period, with a notable peak in 2021.
This data highlights Xencor's aggressive investment strategy, particularly in recent years, as it outpaced TG Therapeutics in R&D spending. Such financial commitments are pivotal for breakthroughs in drug development and maintaining a competitive edge. As these companies continue to innovate, their R&D investments will likely play a crucial role in shaping the future of biotechnology.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
Ascendis Pharma A/S vs Xencor, Inc.: Strategic Focus on R&D Spending
TG Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.